136 related articles for article (PubMed ID: 9047036)
1. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
le Tran Y; Forster C
Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
[TBL] [Abstract][Full Text] [Related]
2. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Li Q; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
[TBL] [Abstract][Full Text] [Related]
3. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
4. Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit.
Hegde SS; Clarke DE
J Pharmacol Exp Ther; 1993 May; 265(2):601-8. PubMed ID: 8496811
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium.
le Tran Y; Forster C
J Cardiovasc Pharmacol; 1997 Nov; 30(5):676-82. PubMed ID: 9388051
[TBL] [Abstract][Full Text] [Related]
6. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
Scott AL; Chang RS; Lotti VJ; Siegl PK
J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
[TBL] [Abstract][Full Text] [Related]
8. Lack of heterologous receptor desensitization induced by angiotensin II type 1 receptor activation in isolated normal rat thoracic aorta.
Pérez T; López RM; López P; Castillo C; Castillo EF
Vascul Pharmacol; 2011; 54(1-2):29-35. PubMed ID: 21122823
[TBL] [Abstract][Full Text] [Related]
9. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
Zwart AS; Davis EA; Widdop RE
Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
[TBL] [Abstract][Full Text] [Related]
10. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
11. The diversified pharmacology of angiotensin II-receptor blockade.
Timmermans PB; Smith RD
Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
[TBL] [Abstract][Full Text] [Related]
12. The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects.
Braszko J
Acta Neurobiol Exp (Wars); 1996; 56(1):49-54. PubMed ID: 8787210
[TBL] [Abstract][Full Text] [Related]
13. Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.
Hong KW; Rhim BY; Shin YW; Yoo SE
J Pharmacol Exp Ther; 1994 Dec; 271(3):1591-6. PubMed ID: 7996473
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
[TBL] [Abstract][Full Text] [Related]
15. Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
Lin K; Chan SH; Chan JY
Synapse; 2001 Apr; 40(1):85-94. PubMed ID: 11170225
[TBL] [Abstract][Full Text] [Related]
16. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
[TBL] [Abstract][Full Text] [Related]
17. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
[TBL] [Abstract][Full Text] [Related]
18. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
[TBL] [Abstract][Full Text] [Related]
19. Interaction between AT1 and alpha1-adrenergic receptors in cardiomyopathic hamsters.
Crespo MJ
J Card Fail; 2000 Sep; 6(3):257-63. PubMed ID: 10997753
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
Ritter JM; Cockcroft JR; Sciberras DG; Goldberg MR
J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
